Kazuhiko Ishikawa

3.0k citations
144 papers · 2.4k indexed · h-index 31

Kazuhiko Ishikawa

140 papers receiving 2.4k citations

Peers

Kazuhiko Ishikawa
Comparison fields: 5 of 121
  • Biotechnology 988
  • Molecular Biology 1.6k
  • Biomedical Engineering 817
  • Nutrition and Dietetics 264
  • Biochemistry 122
Replace Torben V. Borchert with:
Torben V. Borchert Denmark
T. Imanaka Japan
Hannu Maaheimo Finland
Thorsten Eggert Germany
Xueqin Lv China
Mohini S. Ghatge United States
Colin Mitchinson United States
Lujia Zhang China
Robert K. Scopes Australia
Kazuhiko Ishikawa relative to Torben V. Borchert Denmark Torben V. Borchert's profile →
Citations per field
00.5×3.0×
Torben V. Borchert · 1×
Citations per year

Countries citing papers authored by Kazuhiko Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Kazuhiko Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiko Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiko Ishikawa more than expected).

Fields of papers citing papers by Kazuhiko Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiko Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiko Ishikawa. The network helps show where Kazuhiko Ishikawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kazuhiko Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kazuhiko Ishikawa Line = papers co-authored together Kazuhiko Ishikawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20231
4 20231
5 202216
6 201534
7 20144
8 20143
9 201418
10 201430
11 201221
12 201217
13 20083
14 200511
15 200434
16 200337
17 19973
18 19957
19 199214
20 199118

About Kazuhiko Ishikawa

Kazuhiko Ishikawa is a scholar working on Biotechnology, Molecular Biology and Biomedical Engineering, having authored 144 papers that have together received 2.4k indexed citations. Recurring topics across this work include Enzyme Production and Characterization (61 papers), Biofuel production and bioconversion (48 papers), Enzyme Structure and Function (32 papers), Enzyme Catalysis and Immobilization (27 papers), Microbial Metabolic Engineering and Bioproduction (13 papers), Studies on Chitinases and Chitosanases (13 papers), Biochemical and Molecular Research (10 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Biotechnology (988 citations), Molecular Biology (1.6k citations) and Biomedical Engineering (817 citations). Kazuhiko Ishikawa has collaborated with scholars based in Japan, India and South Korea. Frequent co-authors include Ikuo Matsui, Han‐Woo Kim, Hiroyasu Ishida, Koichi Honda, Sung‐Jong Jeon, Hiroyuki Inoue, Tatsuya Fujii, Koshiki Mino, Koichi Uegaki and Yoshitsugu Kosugi. Their work appears in journals such as Bioscience Biotechnology and Biochemistry, FEBS Letters, Biochemistry, FEBS Journal and Applied Biochemistry and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026